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ABSTRACT 
Paraquat is an effective herbicide widely used in India, but is highly toxic on human exposure. Cyclophosphamide is used as pulse therapy in 
combination with methylprednisolone for paraquat poisoning management. Neutropenia and thrombocytopenia are the main side effects which 
may occur with cyclophosphamide in cancer treatment due to bone marrow suppression. Hereby we report a rare case of cyclophosphamide-
induced fatal cytopenia in a patient with paraquat poisoning. This is a case of 24 y old male who came to the emergency department of our hospital 
with a history of alleged consumption of 50 ml of paraquat liquid. On admission, he complained of pain and burning sensation in the throat and 
retrosternal region. Different treatment modalities, namely, pulse therapy with cyclophosphamide and methylprednisolone; and hemoperfusion 
were used to manage patient’s condition. Within few days, the patient developed severe neutropenia and thrombocytopenia. Despite several blood 
transfusions, the patient expired due to fatal manifestations of cytopenia. 
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Paraquat is a widely used bipyridyl contact herbicide having good 
safety records on proper use. Most cases of paraquat poisoning are 
due to suicidal ingestion of the compound. Pulse therapy with 
cyclophosphamide (CP) and methylprednisolone is an effective and 
safe way to treat patients with moderate to severe paraquat 
poisoning [1]. However; pulse therapy was evaluated as a well-
tolerated therapy, spontaneously recovered leucopenia being one 
of the major complications of this. CP is well known to cause 
myelosuppression (leucopenia, neutropenia, thrombocytopenia 
and anemia), bone marrow suppression and severe immune 
suppression which may be fatal [2]. But a short course of CP as 
pulse therapy in paraquat poisoning causing febrile neutropenia and 
thrombocytopenia together is a rare condition. In our knowledge, 
this is the first paraquat poisoning case being reported, where only 3 
d of CP pulse therapy induced severe anemia, leucopenia and 
thrombocytopenia. In spite of giving timely supportive measures, 
the case turned out to be fatal. Ethical permission from institutional 
ethical committee was taken to report the case.  
Case Report 
A 24 y old male patient was admitted to the emergency department of 
Kasturba Medical College and Hospital, Manipal on 5th day of alleged self-
consumption of 50 ml of paraquat along with 50 ml of alcohol. He 
experienced burning and pain in throat and retrosternal region. He 
developed jaundice from 2nd day of consumption of the poison.  
 
Table 1: The laboratory values of the patient in the hospital until death. The first column represents the lab parameters and the second 
column represents their standard values with units. The remaining columns list the lab values on the appropriate day after admission in 
hospital. On days with a dash in the box, the corresponding lab value was not obtained 
Lab parameter Standard value 
and units 
D1 D2 D3 D4 D5 D6 D7 D8 
Hemoglobin 13-17 g/dl 8.4 7.6 7.2 - - 6.0 6.5 6.2 
Hematocrit  40-50% 25.3 23.2 21.7 - - 17.5 18.1 17.9 
Prothrombin Time 13.6-16.9 s - - 17.9 - 18.0 - - 18.3 
Total Bilrubin 0.3-1.2 mg/dl 12.8 - 8.0 11.6 13.2 18.4 - 16.5 
Direct Bilrubin 0-0.4 mg/dl 10.8 - 6.4 9.9 10.7 15 - 14.5 
AST 5-35 U/l 210 - 74 145 91 102 - 94 
ALT 10-40 U/l 121 - 86 132 106 129 - 120 
ALP 20-140 IU/l 166 - 124 96 140 164 - 164 
Urea (Serum) 10-40 mg/dl 90 106 113 131 143 118 81 96 
Serum Creatinine 0.6-1.4 mg/dl 4.8 5.2 2.8 2.9 1.7 1.8 1.1 1.2 
Platelets >150*103 170*103 - - - 23000 20000 28000 21000 
Leucocytes Count 
(WBCs) 
4.1-10.9*103 7800 - - - 2100 1700 900 900 
Neutrophils 45-75 % 77.3 - - - 44 35 27 28 
Lymphocyte 15-44 % 12 - - - 24 30 56 51 
Arterial blood gas details  
pH 7.35-7.45 - - 7.22 7.31 7.50 7.48 7.56 7.60 
SaO2 95-99% 87.4 92.8 84.8 96.9 99.2 99.4 99.6 98.6 
PaCO2 35-48% 16.2 30.8 31.4 33.3 27.8 21.4 27.2 26.6 
FiO2 0.21-1.00 - - 1.0 0.45 0.40 0.42 0.50 0.45 
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Physical examination revealed pallor, icterus and oral ulcers. The vital 
signs and systemic examination were normal. Laboratory investigation 
showed normal platelet count and leukocyte count, but low hemoglobin 
and deranged hepatic and renal function tests [table 1]. 
The patient was started with pulse therapy of methylprednisolone 
(dose of 1g/d) in combination with CP (dose of 1g/d) from 1st day in 
hospital for 3 d to prevent the development of progressive 
pulmonary fibrosis which could lead to respiratory failure. Mesna 
was administered to reduce the risk of urinary bladder 
complications caused by CP. Hemoperfusion was started from 1st 
day in the hospital and continued for 7 d to eliminate the paraquat 
from the body. Empirical antibiotic therapy with piperacillin/ 
tazobactam 4.5 g was started from the first day in the hospital. Anti-
emetic (ondansetron), proton pump inhibitor (omeprazole) and 
dextrose were continued as supportive therapy along with the pulse 
therapy. The patient was also resuscitated with inotropes on the 
first day in the hospital. On 3rd day of admission, the patient 
developed acute respiratory distress syndrome (ARDS) for which 
the patient was intubated.  
On 4th day of admission, the patient developed hospital-acquired 
pneumonia with fever and tachypnea. The patient was administered 
second antibiotic linezolid. On 5th day of admission, hematology reports 
showed leucopenia and thrombocytopenia. Hematology reports 
revealed drop in platelets from 150,000 cells/mm3 to 23,000 cells/mm3 
and leukocyte count from 7800 cells/mm3 to 2100 cells/mm3. On 6th day 
of admission, blood culture report showed the presence of gram-positive 
bacteria (Streptococcus pneumonia) supportive of pneumonia. Hence 
teicoplanin was started at the same day instead of linezolid. He was 
continued with supportive therapies and hemoperfusion.  
On 10th day of the paraquat consumption (i.e. 3rd day after 
completion of pulse therapy) patient’s temperature rose, platelet 
count dropped to 20,000 cells/mm3 and leukocytes dropped to 900 
cells/mm3 with 27% neutrophils. Since hemoglobin also dropped to 
6.5 g/dl, the patient was given packed RBC transfusions for 3 d along 
with platelets transfusion. On 13th day after the consumption, the 
patient’s condition became critical and eventually succumbed to 
septic shock and cytopenia. The patient seemed to be improving 
with respect to renal failure but succumbed to sepsis. 
DISCUSSION 
Paraquat is a contact herbicide used worldwide; mostly in India and 
Sri Lanka. It causes fatal poisoning on human exposure; damages the 
lungs, kidney, and liver. Usually, paraquat gets absorbed rapidly but 
incompletely and gets eliminated unchanged in urine within 12–24 
h. Clinical features are mainly due to intracellular effects. Paraquat 
cause toxicity because it involves in redox-cycling and generates the 
reactive oxygen species (ROS) [3]. Paraquat generates reactive 
oxygen species which cause cellular damage via lipid peroxidation, 
activation of nuclear factor kappa-light-chain-enhancer of activated 
B cells (NF-kB), mitochondrial damage and apoptosis in many 
organs. Toxicity in most of the body organs occurs because of highly 
reactive oxygen and nitrite species generation. The lung bears the 
brunt of injury as paraquat is accumulated in the lung against a 
concentration gradient [3, 4]. 
The literature suggests that pulse therapy with CP and 
methylprednisolone may be an effective and safe way to treat 
patients with moderate to severe paraquat poisoning.  
We can classify the severity of 
paraquat poisoning in three categories. First, mild poisoning in 
which patients develop minor and completely curable 
gastrointestinal symptoms (when patient is found to have 20 mg or 
less paraquat ions/kg of body weight); second is severe poisoning 
(20-40 mg paraquat ions/kg of body weight) in which patients 
develop acute renal failure, acute lung injury with progressive 
pulmonary fibrosis, respiratory failure leading to death in two to 
three weeks; third, fulminant poisoning (>40 mg paraquat ions/kg 
of body weight) in which death occurs because of multiple organ 
failures, within hours to a few days of consumption [5,6]. 
Several studies have looked at the use of CP and steroid therapy. 
Addo and Poon-King (1986) claimed a 72% survival rate in 72 
patients treated with CP (5 mg/kg/d to a maximum total of 4 g) 
and dexamethasone (8 mg eight-hourly over two weeks) [7]. Lin et 
al., 1999; reported results of a prospective, randomized study of 
pulse therapy with cyclophosphamide (1g/d for 2 d) and 
methylprednisolone (1g/d for 3 d) in 142 patients of paraquat 
poisoning [1]. Pulse therapy with CP and methylprednisolone has 
strong evidence on the improvement of the prognosis of patients 
with mild to severe paraquat poisoning. Leucopenia (white blood 
count<3000) was the only major complication of pulse therapy and 
occurred in six of the 16 cases (37-50 %), but in all spontaneous 
recovery occurred within one week [8]. Pulse therapy is evidenced 
as safe and well-tolerated therapy to prevent progressive pulmonary 
fibrosis and respiratory failure. In this case, cytopenia including 
neutropenia and thrombocytopenia resulted in a fatality. Although 
studies have reported the possible role of linezolid to cause 
myelosuppression, it is time dependent and occurs only when it was 
given for 2 w or more [9]. Our case, the cytopenia is unlikely to be 
due to linezolid as the patient had just received 3 d of linezolid. 
CONCLUSION  
CP pulse therapy with methylprednisolone is proven safe and also 
used globally as a treatment of paraquat poisoning. In this case, we 
cannot conclude the exact course of cytopenia but delayed therapy 
can be a cause of fatal outcome as the patient reached the hospital 
on the 5th day. We can take a message home is that we should 
monitor the hematological parameters closely with CP therapy.  
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